Aromatase and CDK4/6 Inhibitor-Induced Musculoskeletal Symptoms: A Systematic Review

SIMPLE SUMMARY: Aromatase inhibitor-induced musculoskeletal symptoms (AIMSS) occurs in up 50% of postmenopausal patients and is the reason for treatment discontinuation in 25% of patients with breast cancer. CDK4/6 inhibitors have been established in the treatment of hormone receptor-positive (HR) b...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrikopoulou, Angeliki, Fiste, Oraianthi, Liontos, Michalis, Dimopoulos, Meletios-Athanasios, Zagouri, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865932/
https://www.ncbi.nlm.nih.gov/pubmed/33530456
http://dx.doi.org/10.3390/cancers13030465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865932/
https://www.ncbi.nlm.nih.gov/pubmed/33530456
http://dx.doi.org/10.3390/cancers13030465

Ejemplares similares